跳至主要内容
临床试验/NCT06436833
NCT06436833招募中不适用

Comparison of Bowel Preparation Using 2 Liter Polyethylene Glycol Regimen Plus Elobixibat Versus 4-Liter Polyethylene Glycol Regimen: a Randomized Controlled Trial

Rajavithi Hospital1 个研究点 分布在 1 个国家目标入组 360 人开始时间: 2024年5月24日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
360
试验地点
1
主要终点
Comparison efficacy of bowel preparation before colonoscopy between 2 group

研究概览

简要总结

Comparison of bowel preparation using 2 liter polyethylene glycol regimen plus elobixibat Versus 4-Liter polyethylene glycol regimen. This study based on hypothesis that show Boston bowel preparation scale which 2L PEG regimen plus Elobixibat have result no significant difference from 4L PEG regimen

详细描述

The trial study in participant who visit to Rajavithi hospital for indication of colonoscopy such as Colorectal cancer screening, Iron deficiency anemia, Chronic diarrhea, chronic constipation, abdominal pain, unintentional weight loss, History of stool occult blood test , abnormal finding from imaging

Randomized participant as above in to two group as bowel preparation regimen Group 1 the participant recieved Polyethylene glycol 2 liter split dose plus Elobixibat 10 milligram.

Group 2 the participant recieved Polyethylene 4 liter split dose

Result of the study show the difference of 2 regimen of bowel preparation which regimen better than another by measuring cleanliness of bowel preparation. The cleanliness of bowel preparation measured by Boston bowel preparation scale

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adute aged 18-80 year old
  • Indication for colonoscopy(one selected)
  • Colorectal cancer screening
  • Stool occult blood test positive
  • History of colonic polyp
  • abdominal pain
  • Iron deficiency anemia
  • Chronic diarrhea
  • chronic constipation
  • Unintentional weight loss
  • Gastrointestinal bleeding
  • Abnormal imagind study
  • Participant acceptconsent information

排除标准

  • Pregnancy or lactation
  • Gastroparesis, gastric outlet obstuction
  • Bowel obstruction
  • Gastrointestinal tract surgery
  • Inflammatory bowel disease
  • ASA(American society of anesthesiologist physical status) status > or = 4
  • Allergic to Elobixibat or PEG
  • Chronic kidney disease stage 4-5(GFR <30 ml/min)
  • Biliary tract obstruction
  • Previous history of inadequate bowel preparation

研究组 & 干预措施

2-Liter polyethylene glycol plus elobixibat

Experimental

Take Elobixibat 10 mg, one day before colonoscopy at 8 a.m. Take Polyethylene glycol 1 Liter, one day before colonoscopy at 8 p.m. Take polyethylene glycol 1 Liter, at day of colonoscopy at 5 a.m.

干预措施: 2-Liter polyethylene glycol plus elobixibat (Drug)

4-Liter polyethylene glycol

Active Comparator

Take Polyethylene glycol 2 Liter, one day before colonoscopy at 8 p.m. Take polyethylene glycol 2 Liter, at day of colonoscopy at 5 a.m.

干预措施: 4-Liter polyethylene glycol (Drug)

结局指标

主要结局

Comparison efficacy of bowel preparation before colonoscopy between 2 group

时间窗: During colonoscopy procedure

Bowel preaparation measure by Boston bowel preparation scale

次要结局

  • Patient satisfaction in their bowel preparation regimen(1 day before colonoscopy)
  • Cecal intubation rate(During colonoscopy procedure)
  • Adenoma detection rate(During colonoscopy procedure)
  • Adverse event in each group(During 24 hour after taking bowel preparation)
  • Overall procedural time of colonoscopy(During colonoscopy procedure)
  • Withdrawal time of colonoscopy(During colonoscopy procedure)

研究者

申办方类型
Other Gov
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验